Back to Search Start Over

Transcriptome-Wide Association Study for Inflammatory Bowel Disease Reveals Novel Candidate Susceptibility Genes in Specific Colon Subsites and Tissue Categories.

Authors :
Díez-Obrero, Virginia
Moratalla-Navarro, Ferran
Ibáñez-Sanz, Gemma
Guardiola, Jordi
Rodríguez-Moranta, Francisco
Obón-Santacana, Mireia
Díez-Villanueva, Anna
Dampier, Christopher Heaton
Devall, Matthew
Carreras-Torres, Robert
Casey, Graham
Moreno, Victor
Source :
Journal of Crohn's & Colitis; Feb2022, Vol. 16 Issue 2, p275-285, 11p
Publication Year :
2022

Abstract

Background and Aims Genome-wide association studies [GWAS] for inflammatory bowel disease [IBD] have identified 240 risk variants. However, the benefit of understanding the genetic architecture of IBD remains to be exploited. Transcriptome-wide association studies [TWAS] associate gene expression with genetic susceptibility to disease, providing functional insight into risk loci. In this study, we integrate relevant datasets for IBD and perform a TWAS to nominate novel genes implicated in IBD genetic susceptibility. Methods We applied elastic net regression to generate gene expression prediction models for the University of Barcelona and University of Virginia RNA sequencing project [BarcUVa-Seq] and correlated expression and disease association research [CEDAR] datasets. Together with Genotype-Tissue Expression project [GTEx] data, and GWAS results from about 60 000 individuals, we employed Summary-PrediXcan and Summary-MultiXcan for single and joint analyses of TWAS results, respectively. Results BarcUVa-Seq TWAS revealed 39 novel genes whose expression in the colon is associated with IBD genetic susceptibility. They included expression markers for specific colon cell types. TWAS meta-analysis including all tissues/cell types provided 186 novel candidate susceptibility genes. Additionally, we identified 78 novel susceptibility genes whose expression is associated with IBD exclusively in immune (N = 19), epithelial (N = 25), mesenchymal (N = 22) and neural (N = 12) tissue categories. Associated genes were involved in relevant molecular pathways, including pathways related to known IBD therapeutics, such as tumour necrosis factor signalling. Conclusion These findings provide insight into tissue-specific molecular processes underlying IBD genetic susceptibility. Associated genes could be candidate targets for new therapeutics and should be prioritized in functional studies. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
18739946
Volume :
16
Issue :
2
Database :
Supplemental Index
Journal :
Journal of Crohn's & Colitis
Publication Type :
Academic Journal
Accession number :
155492832
Full Text :
https://doi.org/10.1093/ecco-jcc/jjab131